The Alfred Mann Foundation‘s first subject, a U.S. Marine, will receive its IMES System (implantable myoelectric sensor). The experimental system could be the first minimally invasive, intuitive, multi-channel control system for prosthetics, intended for long term use. It is being studied under the Investigational Device Exemption regulations of the U.S. Food and Drug Administration. AMF’s ongoing trial with injured veterans at the Walter Reed National Medical Military Center anticipates subjects intuitively operating three prosthetic movements simultaneously: opening and closing the hand, rotating the wrist, and moving the thumb.
While the IMES system focuses on muscle activation, it is our opinion that the future of prosthetics will include a combination of brain (possibly non-invasive) and muscle interpretation.